The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer Article Swipe
Michael J. Raphael
,
William Raskin
,
Steven Habbous
,
Xiaochen Tai
,
Jaclyn Beca
,
Wei Fang Dai
,
Jessica Arias
,
Leta Forbes
,
Scott Gavura
,
James Biagi
,
Craig C. Earle
,
Kelvin Chan
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1001/jamanetworkopen.2021.33388
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1001/jamanetworkopen.2021.33388
This cohort study of patients with advanced pancreatic cancer receiving first-line palliative chemotherapy within a universal health care system found that drug funding decisions were associated with increased uptake of new treatment options over time and improved survival. Both FOLFIRINOX and GEMNAB were associated with survival benefits in distinct patient populations.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1001/jamanetworkopen.2021.33388
- https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786135/raphael_2021_oi_210944_1636051224.85765.pdf
- OA Status
- gold
- Cited By
- 8
- References
- 23
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3213606362
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3213606362Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1001/jamanetworkopen.2021.33388Digital Object Identifier
- Title
-
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic CancerWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-11-15Full publication date if available
- Authors
-
Michael J. Raphael, William Raskin, Steven Habbous, Xiaochen Tai, Jaclyn Beca, Wei Fang Dai, Jessica Arias, Leta Forbes, Scott Gavura, James Biagi, Craig C. Earle, Kelvin ChanList of authors in order
- Landing page
-
https://doi.org/10.1001/jamanetworkopen.2021.33388Publisher landing page
- PDF URL
-
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786135/raphael_2021_oi_210944_1636051224.85765.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786135/raphael_2021_oi_210944_1636051224.85765.pdfDirect OA link when available
- Concepts
-
FOLFIRINOX, Gemcitabine, Medicine, Irinotecan, Pancreatic cancer, Internal medicine, Regimen, Oncology, Cancer registry, Population, Retrospective cohort study, Cancer, Oxaliplatin, Proportional hazards model, Colorectal cancer, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
8Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 4, 2022: 1, 2021: 1Per-year citation counts (last 5 years)
- References (count)
-
23Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3213606362 |
|---|---|
| doi | https://doi.org/10.1001/jamanetworkopen.2021.33388 |
| ids.doi | https://doi.org/10.1001/jamanetworkopen.2021.33388 |
| ids.mag | 3213606362 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/34779846 |
| ids.openalex | https://openalex.org/W3213606362 |
| fwci | 0.62898896 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000368 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Aged |
| mesh[2].qualifier_ui | Q000191 |
| mesh[2].descriptor_ui | D000971 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | economics |
| mesh[2].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[3].qualifier_ui | Q000627 |
| mesh[3].descriptor_ui | D000971 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | therapeutic use |
| mesh[3].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D015331 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Cohort Studies |
| mesh[5].qualifier_ui | Q000031 |
| mesh[5].descriptor_ui | D003841 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | analogs & derivatives |
| mesh[5].descriptor_name | Deoxycytidine |
| mesh[6].qualifier_ui | Q000191 |
| mesh[6].descriptor_ui | D003841 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | economics |
| mesh[6].descriptor_name | Deoxycytidine |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D003841 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Deoxycytidine |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D005260 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Female |
| mesh[9].qualifier_ui | Q000191 |
| mesh[9].descriptor_ui | D005472 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | economics |
| mesh[9].descriptor_name | Fluorouracil |
| mesh[10].qualifier_ui | Q000627 |
| mesh[10].descriptor_ui | D005472 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | therapeutic use |
| mesh[10].descriptor_name | Fluorouracil |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | Q000191 |
| mesh[12].descriptor_ui | D000077146 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | economics |
| mesh[12].descriptor_name | Irinotecan |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D000077146 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Irinotecan |
| mesh[14].qualifier_ui | Q000191 |
| mesh[14].descriptor_ui | D002955 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | economics |
| mesh[14].descriptor_name | Leucovorin |
| mesh[15].qualifier_ui | Q000627 |
| mesh[15].descriptor_ui | D002955 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | therapeutic use |
| mesh[15].descriptor_name | Leucovorin |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D008297 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Male |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D008875 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Middle Aged |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D009864 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Ontario |
| mesh[19].qualifier_ui | Q000191 |
| mesh[19].descriptor_ui | D000077150 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | economics |
| mesh[19].descriptor_name | Oxaliplatin |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D000077150 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Oxaliplatin |
| mesh[21].qualifier_ui | Q000191 |
| mesh[21].descriptor_ui | D010166 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | economics |
| mesh[21].descriptor_name | Palliative Care |
| mesh[22].qualifier_ui | Q000188 |
| mesh[22].descriptor_ui | D010190 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | drug therapy |
| mesh[22].descriptor_name | Pancreatic Neoplasms |
| mesh[23].qualifier_ui | Q000191 |
| mesh[23].descriptor_ui | D010190 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | economics |
| mesh[23].descriptor_name | Pancreatic Neoplasms |
| mesh[24].qualifier_ui | Q000401 |
| mesh[24].descriptor_ui | D010190 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | mortality |
| mesh[24].descriptor_name | Pancreatic Neoplasms |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D012189 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Retrospective Studies |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D015996 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Survival Rate |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D000093542 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Gemcitabine |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D010190 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Pancreatic Neoplasms |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D000328 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Adult |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000368 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Aged |
| mesh[31].qualifier_ui | Q000191 |
| mesh[31].descriptor_ui | D000971 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | economics |
| mesh[31].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[32].qualifier_ui | Q000627 |
| mesh[32].descriptor_ui | D000971 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | therapeutic use |
| mesh[32].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D015331 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Cohort Studies |
| mesh[34].qualifier_ui | Q000031 |
| mesh[34].descriptor_ui | D003841 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | analogs & derivatives |
| mesh[34].descriptor_name | Deoxycytidine |
| mesh[35].qualifier_ui | Q000191 |
| mesh[35].descriptor_ui | D003841 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | economics |
| mesh[35].descriptor_name | Deoxycytidine |
| mesh[36].qualifier_ui | Q000627 |
| mesh[36].descriptor_ui | D003841 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | therapeutic use |
| mesh[36].descriptor_name | Deoxycytidine |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D005260 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Female |
| mesh[38].qualifier_ui | Q000191 |
| mesh[38].descriptor_ui | D005472 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | economics |
| mesh[38].descriptor_name | Fluorouracil |
| mesh[39].qualifier_ui | Q000627 |
| mesh[39].descriptor_ui | D005472 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | therapeutic use |
| mesh[39].descriptor_name | Fluorouracil |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D006801 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Humans |
| mesh[41].qualifier_ui | Q000191 |
| mesh[41].descriptor_ui | D000077146 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | economics |
| mesh[41].descriptor_name | Irinotecan |
| mesh[42].qualifier_ui | Q000627 |
| mesh[42].descriptor_ui | D000077146 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | therapeutic use |
| mesh[42].descriptor_name | Irinotecan |
| mesh[43].qualifier_ui | Q000191 |
| mesh[43].descriptor_ui | D002955 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | economics |
| mesh[43].descriptor_name | Leucovorin |
| mesh[44].qualifier_ui | Q000627 |
| mesh[44].descriptor_ui | D002955 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | therapeutic use |
| mesh[44].descriptor_name | Leucovorin |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D008297 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Male |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D008875 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Middle Aged |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D009864 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Ontario |
| mesh[48].qualifier_ui | Q000191 |
| mesh[48].descriptor_ui | D000077150 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | economics |
| mesh[48].descriptor_name | Oxaliplatin |
| mesh[49].qualifier_ui | Q000627 |
| mesh[49].descriptor_ui | D000077150 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | therapeutic use |
| mesh[49].descriptor_name | Oxaliplatin |
| type | article |
| title | The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer |
| biblio.issue | 11 |
| biblio.volume | 4 |
| biblio.last_page | e2133388 |
| biblio.first_page | e2133388 |
| topics[0].id | https://openalex.org/T10231 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Pancreatic and Hepatic Oncology Research |
| topics[1].id | https://openalex.org/T12708 |
| topics[1].field.id | https://openalex.org/fields/20 |
| topics[1].field.display_name | Economics, Econometrics and Finance |
| topics[1].score | 0.9948999881744385 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2002 |
| topics[1].subfield.display_name | Economics and Econometrics |
| topics[1].display_name | Economic and Financial Impacts of Cancer |
| topics[2].id | https://openalex.org/T10804 |
| topics[2].field.id | https://openalex.org/fields/20 |
| topics[2].field.display_name | Economics, Econometrics and Finance |
| topics[2].score | 0.9807999730110168 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2002 |
| topics[2].subfield.display_name | Economics and Econometrics |
| topics[2].display_name | Health Systems, Economic Evaluations, Quality of Life |
| is_xpac | False |
| apc_list.value | 3000 |
| apc_list.currency | USD |
| apc_list.value_usd | 3000 |
| apc_paid.value | 3000 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3000 |
| concepts[0].id | https://openalex.org/C2777148230 |
| concepts[0].level | 5 |
| concepts[0].score | 0.8897570967674255 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q17144959 |
| concepts[0].display_name | FOLFIRINOX |
| concepts[1].id | https://openalex.org/C2780258809 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8444647789001465 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q414143 |
| concepts[1].display_name | Gemcitabine |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.8384911417961121 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2780259306 |
| concepts[3].level | 4 |
| concepts[3].score | 0.7579490542411804 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q412197 |
| concepts[3].display_name | Irinotecan |
| concepts[4].id | https://openalex.org/C2780210213 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6517742276191711 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q212961 |
| concepts[4].display_name | Pancreatic cancer |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.6454375386238098 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C2781413609 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5909991264343262 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7308373 |
| concepts[6].display_name | Regimen |
| concepts[7].id | https://openalex.org/C143998085 |
| concepts[7].level | 1 |
| concepts[7].score | 0.5867184996604919 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[7].display_name | Oncology |
| concepts[8].id | https://openalex.org/C2778527826 |
| concepts[8].level | 3 |
| concepts[8].score | 0.49792981147766113 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1787017 |
| concepts[8].display_name | Cancer registry |
| concepts[9].id | https://openalex.org/C2908647359 |
| concepts[9].level | 2 |
| concepts[9].score | 0.47336265444755554 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[9].display_name | Population |
| concepts[10].id | https://openalex.org/C167135981 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4480847418308258 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[10].display_name | Retrospective cohort study |
| concepts[11].id | https://openalex.org/C121608353 |
| concepts[11].level | 2 |
| concepts[11].score | 0.44781920313835144 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[11].display_name | Cancer |
| concepts[12].id | https://openalex.org/C2780962732 |
| concepts[12].level | 4 |
| concepts[12].score | 0.42994749546051025 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q422327 |
| concepts[12].display_name | Oxaliplatin |
| concepts[13].id | https://openalex.org/C50382708 |
| concepts[13].level | 2 |
| concepts[13].score | 0.4267321527004242 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q223218 |
| concepts[13].display_name | Proportional hazards model |
| concepts[14].id | https://openalex.org/C526805850 |
| concepts[14].level | 3 |
| concepts[14].score | 0.10023659467697144 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[14].display_name | Colorectal cancer |
| concepts[15].id | https://openalex.org/C99454951 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[15].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/folfirinox |
| keywords[0].score | 0.8897570967674255 |
| keywords[0].display_name | FOLFIRINOX |
| keywords[1].id | https://openalex.org/keywords/gemcitabine |
| keywords[1].score | 0.8444647789001465 |
| keywords[1].display_name | Gemcitabine |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.8384911417961121 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/irinotecan |
| keywords[3].score | 0.7579490542411804 |
| keywords[3].display_name | Irinotecan |
| keywords[4].id | https://openalex.org/keywords/pancreatic-cancer |
| keywords[4].score | 0.6517742276191711 |
| keywords[4].display_name | Pancreatic cancer |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.6454375386238098 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/regimen |
| keywords[6].score | 0.5909991264343262 |
| keywords[6].display_name | Regimen |
| keywords[7].id | https://openalex.org/keywords/oncology |
| keywords[7].score | 0.5867184996604919 |
| keywords[7].display_name | Oncology |
| keywords[8].id | https://openalex.org/keywords/cancer-registry |
| keywords[8].score | 0.49792981147766113 |
| keywords[8].display_name | Cancer registry |
| keywords[9].id | https://openalex.org/keywords/population |
| keywords[9].score | 0.47336265444755554 |
| keywords[9].display_name | Population |
| keywords[10].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[10].score | 0.4480847418308258 |
| keywords[10].display_name | Retrospective cohort study |
| keywords[11].id | https://openalex.org/keywords/cancer |
| keywords[11].score | 0.44781920313835144 |
| keywords[11].display_name | Cancer |
| keywords[12].id | https://openalex.org/keywords/oxaliplatin |
| keywords[12].score | 0.42994749546051025 |
| keywords[12].display_name | Oxaliplatin |
| keywords[13].id | https://openalex.org/keywords/proportional-hazards-model |
| keywords[13].score | 0.4267321527004242 |
| keywords[13].display_name | Proportional hazards model |
| keywords[14].id | https://openalex.org/keywords/colorectal-cancer |
| keywords[14].score | 0.10023659467697144 |
| keywords[14].display_name | Colorectal cancer |
| language | en |
| locations[0].id | doi:10.1001/jamanetworkopen.2021.33388 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210217848 |
| locations[0].source.issn | 2574-3805 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2574-3805 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | JAMA Network Open |
| locations[0].source.host_organization | https://openalex.org/P4310320259 |
| locations[0].source.host_organization_name | American Medical Association |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320259 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786135/raphael_2021_oi_210944_1636051224.85765.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | JAMA Network Open |
| locations[0].landing_page_url | https://doi.org/10.1001/jamanetworkopen.2021.33388 |
| locations[1].id | pmid:34779846 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | JAMA network open |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/34779846 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:8593760 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | JAMA Netw Open |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8593760 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5053112746 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3301-2388 |
| authorships[0].author.display_name | Michael J. Raphael |
| authorships[0].countries | CA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1323843004, https://openalex.org/I185261750, https://openalex.org/I2802362269 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210153208 |
| authorships[0].affiliations[1].raw_affiliation_string | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I23965814 |
| authorships[0].affiliations[2].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[0].institutions[0].id | https://openalex.org/I4210153208 |
| authorships[0].institutions[0].ror | https://ror.org/05wpaeg31 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210153208 |
| authorships[0].institutions[0].country_code | CA |
| authorships[0].institutions[0].display_name | Canadian Centre for Applied Research in Cancer Control |
| authorships[0].institutions[1].id | https://openalex.org/I23965814 |
| authorships[0].institutions[1].ror | https://ror.org/029n6xw55 |
| authorships[0].institutions[1].type | government |
| authorships[0].institutions[1].lineage | https://openalex.org/I23965814 |
| authorships[0].institutions[1].country_code | CA |
| authorships[0].institutions[1].display_name | Cancer Care Ontario |
| authorships[0].institutions[2].id | https://openalex.org/I2802362269 |
| authorships[0].institutions[2].ror | https://ror.org/05pr37258 |
| authorships[0].institutions[2].type | healthcare |
| authorships[0].institutions[2].lineage | https://openalex.org/I110535807, https://openalex.org/I2802362269 |
| authorships[0].institutions[2].country_code | CA |
| authorships[0].institutions[2].display_name | Health Sciences Centre |
| authorships[0].institutions[3].id | https://openalex.org/I1323843004 |
| authorships[0].institutions[3].ror | https://ror.org/03wefcv03 |
| authorships[0].institutions[3].type | healthcare |
| authorships[0].institutions[3].lineage | https://openalex.org/I1323843004 |
| authorships[0].institutions[3].country_code | CA |
| authorships[0].institutions[3].display_name | Sunnybrook Health Science Centre |
| authorships[0].institutions[4].id | https://openalex.org/I185261750 |
| authorships[0].institutions[4].ror | https://ror.org/03dbr7087 |
| authorships[0].institutions[4].type | education |
| authorships[0].institutions[4].lineage | https://openalex.org/I185261750 |
| authorships[0].institutions[4].country_code | CA |
| authorships[0].institutions[4].display_name | University of Toronto |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Michael J. Raphael |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada, Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada, Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[1].author.id | https://openalex.org/A5071529887 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | William Raskin |
| authorships[1].countries | CA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210129503 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Oncology, William Osler Health System, Brampton, Ontario, Canada |
| authorships[1].institutions[0].id | https://openalex.org/I4210129503 |
| authorships[1].institutions[0].ror | https://ror.org/03d1xjg58 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210129503 |
| authorships[1].institutions[0].country_code | CA |
| authorships[1].institutions[0].display_name | William Osler Health System |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | William Raskin |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Oncology, William Osler Health System, Brampton, Ontario, Canada |
| authorships[2].author.id | https://openalex.org/A5070447889 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9650-9105 |
| authorships[2].author.display_name | Steven Habbous |
| authorships[2].countries | CA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I23965814 |
| authorships[2].affiliations[0].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[2].institutions[0].id | https://openalex.org/I23965814 |
| authorships[2].institutions[0].ror | https://ror.org/029n6xw55 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I23965814 |
| authorships[2].institutions[0].country_code | CA |
| authorships[2].institutions[0].display_name | Cancer Care Ontario |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Steven Habbous |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[3].author.id | https://openalex.org/A5039233562 |
| authorships[3].author.orcid | https://orcid.org/0009-0002-1971-6837 |
| authorships[3].author.display_name | Xiaochen Tai |
| authorships[3].countries | CA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I23965814 |
| authorships[3].affiliations[0].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[3].institutions[0].id | https://openalex.org/I23965814 |
| authorships[3].institutions[0].ror | https://ror.org/029n6xw55 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I23965814 |
| authorships[3].institutions[0].country_code | CA |
| authorships[3].institutions[0].display_name | Cancer Care Ontario |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Xiaochen Tai |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[4].author.id | https://openalex.org/A5085932488 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8858-9566 |
| authorships[4].author.display_name | Jaclyn Beca |
| authorships[4].countries | CA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I23965814 |
| authorships[4].affiliations[0].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[4].institutions[0].id | https://openalex.org/I23965814 |
| authorships[4].institutions[0].ror | https://ror.org/029n6xw55 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I23965814 |
| authorships[4].institutions[0].country_code | CA |
| authorships[4].institutions[0].display_name | Cancer Care Ontario |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jaclyn Beca |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[5].author.id | https://openalex.org/A5101571343 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-1416-1070 |
| authorships[5].author.display_name | Wei Fang Dai |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210153208 |
| authorships[5].affiliations[0].raw_affiliation_string | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I23965814 |
| authorships[5].affiliations[1].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[5].institutions[0].id | https://openalex.org/I4210153208 |
| authorships[5].institutions[0].ror | https://ror.org/05wpaeg31 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210153208 |
| authorships[5].institutions[0].country_code | CA |
| authorships[5].institutions[0].display_name | Canadian Centre for Applied Research in Cancer Control |
| authorships[5].institutions[1].id | https://openalex.org/I23965814 |
| authorships[5].institutions[1].ror | https://ror.org/029n6xw55 |
| authorships[5].institutions[1].type | government |
| authorships[5].institutions[1].lineage | https://openalex.org/I23965814 |
| authorships[5].institutions[1].country_code | CA |
| authorships[5].institutions[1].display_name | Cancer Care Ontario |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Wei F. Dai |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada, Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[6].author.id | https://openalex.org/A5110661824 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Jessica Arias |
| authorships[6].countries | CA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210153208 |
| authorships[6].affiliations[0].raw_affiliation_string | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I23965814 |
| authorships[6].affiliations[1].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[6].institutions[0].id | https://openalex.org/I4210153208 |
| authorships[6].institutions[0].ror | https://ror.org/05wpaeg31 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210153208 |
| authorships[6].institutions[0].country_code | CA |
| authorships[6].institutions[0].display_name | Canadian Centre for Applied Research in Cancer Control |
| authorships[6].institutions[1].id | https://openalex.org/I23965814 |
| authorships[6].institutions[1].ror | https://ror.org/029n6xw55 |
| authorships[6].institutions[1].type | government |
| authorships[6].institutions[1].lineage | https://openalex.org/I23965814 |
| authorships[6].institutions[1].country_code | CA |
| authorships[6].institutions[1].display_name | Cancer Care Ontario |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Jessica Arias |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada, Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[7].author.id | https://openalex.org/A5030716267 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Leta Forbes |
| authorships[7].countries | CA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I23965814 |
| authorships[7].affiliations[0].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[7].institutions[0].id | https://openalex.org/I23965814 |
| authorships[7].institutions[0].ror | https://ror.org/029n6xw55 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I23965814 |
| authorships[7].institutions[0].country_code | CA |
| authorships[7].institutions[0].display_name | Cancer Care Ontario |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Leta Forbes |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[8].author.id | https://openalex.org/A5063835785 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-8635-6889 |
| authorships[8].author.display_name | Scott Gavura |
| authorships[8].countries | CA |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I23965814 |
| authorships[8].affiliations[0].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[8].institutions[0].id | https://openalex.org/I23965814 |
| authorships[8].institutions[0].ror | https://ror.org/029n6xw55 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I23965814 |
| authorships[8].institutions[0].country_code | CA |
| authorships[8].institutions[0].display_name | Cancer Care Ontario |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Scott Gavura |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[9].author.id | https://openalex.org/A5025627496 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-9233-7396 |
| authorships[9].author.display_name | James Biagi |
| authorships[9].countries | CA |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I204722609 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Oncology, Queen's University, Kingston, Ontario, Canada |
| authorships[9].institutions[0].id | https://openalex.org/I204722609 |
| authorships[9].institutions[0].ror | https://ror.org/02y72wh86 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I204722609 |
| authorships[9].institutions[0].country_code | CA |
| authorships[9].institutions[0].display_name | Queen's University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | James J. Biagi |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Oncology, Queen's University, Kingston, Ontario, Canada |
| authorships[10].author.id | https://openalex.org/A5002447665 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0420-1999 |
| authorships[10].author.display_name | Craig C. Earle |
| authorships[10].countries | CA |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1323843004, https://openalex.org/I185261750, https://openalex.org/I2802362269 |
| authorships[10].affiliations[0].raw_affiliation_string | Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I4210153208 |
| authorships[10].affiliations[1].raw_affiliation_string | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada |
| authorships[10].institutions[0].id | https://openalex.org/I4210153208 |
| authorships[10].institutions[0].ror | https://ror.org/05wpaeg31 |
| authorships[10].institutions[0].type | facility |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210153208 |
| authorships[10].institutions[0].country_code | CA |
| authorships[10].institutions[0].display_name | Canadian Centre for Applied Research in Cancer Control |
| authorships[10].institutions[1].id | https://openalex.org/I2802362269 |
| authorships[10].institutions[1].ror | https://ror.org/05pr37258 |
| authorships[10].institutions[1].type | healthcare |
| authorships[10].institutions[1].lineage | https://openalex.org/I110535807, https://openalex.org/I2802362269 |
| authorships[10].institutions[1].country_code | CA |
| authorships[10].institutions[1].display_name | Health Sciences Centre |
| authorships[10].institutions[2].id | https://openalex.org/I1323843004 |
| authorships[10].institutions[2].ror | https://ror.org/03wefcv03 |
| authorships[10].institutions[2].type | healthcare |
| authorships[10].institutions[2].lineage | https://openalex.org/I1323843004 |
| authorships[10].institutions[2].country_code | CA |
| authorships[10].institutions[2].display_name | Sunnybrook Health Science Centre |
| authorships[10].institutions[3].id | https://openalex.org/I185261750 |
| authorships[10].institutions[3].ror | https://ror.org/03dbr7087 |
| authorships[10].institutions[3].type | education |
| authorships[10].institutions[3].lineage | https://openalex.org/I185261750 |
| authorships[10].institutions[3].country_code | CA |
| authorships[10].institutions[3].display_name | University of Toronto |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Craig C. Earle |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada, Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada |
| authorships[11].author.id | https://openalex.org/A5008282524 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2501-3057 |
| authorships[11].author.display_name | Kelvin Chan |
| authorships[11].countries | CA |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I23965814 |
| authorships[11].affiliations[0].raw_affiliation_string | Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I1323843004, https://openalex.org/I185261750, https://openalex.org/I2802362269 |
| authorships[11].affiliations[1].raw_affiliation_string | Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada |
| authorships[11].affiliations[2].institution_ids | https://openalex.org/I4210153208 |
| authorships[11].affiliations[2].raw_affiliation_string | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada |
| authorships[11].institutions[0].id | https://openalex.org/I4210153208 |
| authorships[11].institutions[0].ror | https://ror.org/05wpaeg31 |
| authorships[11].institutions[0].type | facility |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210153208 |
| authorships[11].institutions[0].country_code | CA |
| authorships[11].institutions[0].display_name | Canadian Centre for Applied Research in Cancer Control |
| authorships[11].institutions[1].id | https://openalex.org/I23965814 |
| authorships[11].institutions[1].ror | https://ror.org/029n6xw55 |
| authorships[11].institutions[1].type | government |
| authorships[11].institutions[1].lineage | https://openalex.org/I23965814 |
| authorships[11].institutions[1].country_code | CA |
| authorships[11].institutions[1].display_name | Cancer Care Ontario |
| authorships[11].institutions[2].id | https://openalex.org/I2802362269 |
| authorships[11].institutions[2].ror | https://ror.org/05pr37258 |
| authorships[11].institutions[2].type | healthcare |
| authorships[11].institutions[2].lineage | https://openalex.org/I110535807, https://openalex.org/I2802362269 |
| authorships[11].institutions[2].country_code | CA |
| authorships[11].institutions[2].display_name | Health Sciences Centre |
| authorships[11].institutions[3].id | https://openalex.org/I1323843004 |
| authorships[11].institutions[3].ror | https://ror.org/03wefcv03 |
| authorships[11].institutions[3].type | healthcare |
| authorships[11].institutions[3].lineage | https://openalex.org/I1323843004 |
| authorships[11].institutions[3].country_code | CA |
| authorships[11].institutions[3].display_name | Sunnybrook Health Science Centre |
| authorships[11].institutions[4].id | https://openalex.org/I185261750 |
| authorships[11].institutions[4].ror | https://ror.org/03dbr7087 |
| authorships[11].institutions[4].type | education |
| authorships[11].institutions[4].lineage | https://openalex.org/I185261750 |
| authorships[11].institutions[4].country_code | CA |
| authorships[11].institutions[4].display_name | University of Toronto |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Kelvin K. W. Chan |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada, Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada, Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786135/raphael_2021_oi_210944_1636051224.85765.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10231 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Pancreatic and Hepatic Oncology Research |
| related_works | https://openalex.org/W3114075133, https://openalex.org/W4205173692, https://openalex.org/W2004787353, https://openalex.org/W2358342218, https://openalex.org/W2142100270, https://openalex.org/W2991183880, https://openalex.org/W2016785168, https://openalex.org/W1982756255, https://openalex.org/W2082598176, https://openalex.org/W2039734044 |
| cited_by_count | 8 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1001/jamanetworkopen.2021.33388 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210217848 |
| best_oa_location.source.issn | 2574-3805 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2574-3805 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | JAMA Network Open |
| best_oa_location.source.host_organization | https://openalex.org/P4310320259 |
| best_oa_location.source.host_organization_name | American Medical Association |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320259 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786135/raphael_2021_oi_210944_1636051224.85765.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | JAMA Network Open |
| best_oa_location.landing_page_url | https://doi.org/10.1001/jamanetworkopen.2021.33388 |
| primary_location.id | doi:10.1001/jamanetworkopen.2021.33388 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210217848 |
| primary_location.source.issn | 2574-3805 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2574-3805 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | JAMA Network Open |
| primary_location.source.host_organization | https://openalex.org/P4310320259 |
| primary_location.source.host_organization_name | American Medical Association |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320259 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786135/raphael_2021_oi_210944_1636051224.85765.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | JAMA Network Open |
| primary_location.landing_page_url | https://doi.org/10.1001/jamanetworkopen.2021.33388 |
| publication_date | 2021-11-15 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W1931508686, https://openalex.org/W2165480504, https://openalex.org/W2151253787, https://openalex.org/W2143802196, https://openalex.org/W2164286021, https://openalex.org/W2804017601, https://openalex.org/W2571282247, https://openalex.org/W4249475443, https://openalex.org/W3000283591, https://openalex.org/W2055557358, https://openalex.org/W2913253891, https://openalex.org/W2129168200, https://openalex.org/W1935122906, https://openalex.org/W2036193982, https://openalex.org/W1975994236, https://openalex.org/W2126049444, https://openalex.org/W2152849583, https://openalex.org/W2946325513, https://openalex.org/W4249309611, https://openalex.org/W2998791752, https://openalex.org/W2903623792, https://openalex.org/W3089805575, https://openalex.org/W2805464686 |
| referenced_works_count | 23 |
| abstract_inverted_index.a | 14 |
| abstract_inverted_index.in | 47 |
| abstract_inverted_index.of | 3, 29 |
| abstract_inverted_index.and | 35, 40 |
| abstract_inverted_index.new | 30 |
| abstract_inverted_index.Both | 38 |
| abstract_inverted_index.This | 0 |
| abstract_inverted_index.care | 17 |
| abstract_inverted_index.drug | 21 |
| abstract_inverted_index.over | 33 |
| abstract_inverted_index.that | 20 |
| abstract_inverted_index.time | 34 |
| abstract_inverted_index.were | 24, 42 |
| abstract_inverted_index.with | 5, 26, 44 |
| abstract_inverted_index.found | 19 |
| abstract_inverted_index.study | 2 |
| abstract_inverted_index.GEMNAB | 41 |
| abstract_inverted_index.cancer | 8 |
| abstract_inverted_index.cohort | 1 |
| abstract_inverted_index.health | 16 |
| abstract_inverted_index.system | 18 |
| abstract_inverted_index.uptake | 28 |
| abstract_inverted_index.within | 13 |
| abstract_inverted_index.funding | 22 |
| abstract_inverted_index.options | 32 |
| abstract_inverted_index.patient | 49 |
| abstract_inverted_index.advanced | 6 |
| abstract_inverted_index.benefits | 46 |
| abstract_inverted_index.distinct | 48 |
| abstract_inverted_index.improved | 36 |
| abstract_inverted_index.patients | 4 |
| abstract_inverted_index.survival | 45 |
| abstract_inverted_index.decisions | 23 |
| abstract_inverted_index.increased | 27 |
| abstract_inverted_index.receiving | 9 |
| abstract_inverted_index.survival. | 37 |
| abstract_inverted_index.treatment | 31 |
| abstract_inverted_index.universal | 15 |
| abstract_inverted_index.FOLFIRINOX | 39 |
| abstract_inverted_index.associated | 25, 43 |
| abstract_inverted_index.first-line | 10 |
| abstract_inverted_index.palliative | 11 |
| abstract_inverted_index.pancreatic | 7 |
| abstract_inverted_index.chemotherapy | 12 |
| abstract_inverted_index.populations. | 50 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5053112746 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| corresponding_institution_ids | https://openalex.org/I1323843004, https://openalex.org/I185261750, https://openalex.org/I23965814, https://openalex.org/I2802362269, https://openalex.org/I4210153208 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7200000286102295 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.70081985 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |